Andrew F. Leuchter, MD, is a Professor in the Department of Psychiatry and Biobehavioral Science at the University of California, Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior at UCLA. He also is Director of the Laboratory of Brain, Behavior, and Pharmacology and Senior Research Scientist at the Semel Institute for Neuroscience and Human Behavior at UCLA.

A graduate of Stanford University, Dr. Leuchter earned his medical degree from Baylor College of Medicine in Houston, Texas. He completed internships in Medicine/Neurology at the Wadsworth Veterans Administration Medical Center and in Geroneuropsychiatry/Neurology at the UCLA Neuropsychiatric Institute. He then served a residency in Psychiatry at the UCLA Neuropsychiatric Institute and a Robert Wood Johnson Fellowship in the UCLA Department of Medicine.

Dr. Leuchterís research focuses on the enhancement of treatment outcomes in depression. He uses brain-imaging techniques, such as quantitative electroencephalography (QEEG), magnetic resonance imaging (MRI), and positron emission tomography (PET), to examine brain function and predict which treatments are most likely to benefit individual patients. His research program combines clinical trials with neurophysiologic and brain-imaging studies to inform clinical practice in the treatment of depression.

Dr. Leuchter is a Diplomate of the American Board of Electroencephalography and Neurophysiology and a Diplomate in Psychiatry and Neurology with Added Qualifications in Geriatric Psychiatry.  He is a member of several professional organizations, including the American Psychiatric Association, American Psychiatric Electrophysiology Association, and the American Medical EEG Association.  A frequently published author, he is a reviewer for a number of scientific journals, such as Archives of General Psychiatry, International Journal of Geriatric Psychiatry, and the Journal of the American Psychiatric Association.